Table 1.
Baseline characteristics between PLA2R-associated and non-PLA2R -associated groups
| PLA2R-associated | non-PLA2R-associated | P value | |
|---|---|---|---|
| Patients | 78 | 13 | |
| CTX % | 47.4% (37/78) | 61.5% (8/13) | 0.346 |
| Gender (M:F) | 52:26 | 5:8 | 0.102 |
| Age (year) | 53.81 ± 14.64 | 53.54 ± 17.52 | 0.953 |
| Urine Protein (g/24 h) | 5.51 (4.02, 7.72) | 5.23 (2.34, 12.51) | 0.829 |
| Albumin (g/L) | 19.45 ± 5.05 | 21.58 ± 9.07 | 0.423 |
| Creatinine (μmmol/L) | 78 (61.65, 93.75) | 68.6 (60, 132.5) | 0.875 |
| Cholesterol (mmol/L) | 7.86 ± 2.69 | 6.93 ± 1.88 | 0.238 |
| Triglyceride (mmol/L) | 2.1 (1.77, 3.21) | 1.82 (1.57, 2.98) | 0.434 |
| Systolic Pressure (mmHg) | 131.82 ± 17.99 | 121.54 ± 12.91 | 0.052 |
| Diastolic pressure (mmHg) | 80 (72, 90) | 80 (66, 81) | 0.180 |